Credit Suisse reaffirmed their outperform rating on shares of IAC/InterActiveCorp (NASDAQ:IACI) in a report issued on Thursday. They currently have a $72.00 target price on the stock, down from their previous target price of $76.00. IAC/InterActiveCorp (NASDAQ:IACI) belongs to Technology sector. Its net profit margin is 14.00% and weekly performance is -1.06%. On last trading day company shares ended up $64.30. IAC/InterActiveCorp (NASDAQ:IACI) distance from 50-day simple moving average (SMA50) is 0.64%.

On Nov 26, Micron Technology, Inc. (NASDAQ:MU)announced that Ronald C. Foster, Chief Financial Officer (CFO) and Vice President of Finance, will retire from Micron next year. Micron Technology, Inc. (NASDAQ:MU) shares fell -2.67% in last trading session and ended the day at $34.99. MU Gross Margin is 33.20% and its return on assets is 14.60%. Micron Technology, Inc. (NASDAQ:MU) quarterly performance is 11.04%.

Astellas Pharma Europe Ltd. announced that the Ecopetrol SA (NYSE:EC) has granted a variation to amend the Marketing Authorisation for enzalutamide (trade name XTANDI). Enzalutamide is now approved in Europe for the treatment of adult men with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. Ecopetrol SA (NYSE:EC) belongs to Basic Materials sector. Its net profit margin is 15.40% and weekly performance is -20.80%. On last trading day company shares ended up $20.11. Ecopetrol SA (NYSE:EC) distance from 50-day simple moving average (SMA50) is -28.13%.

Cypress Semiconductor Corporation (NASDAQ:CY) will buy peer Spansion Inc for $1.59 billion in stock, creating a chipmaker with more than $2 billion in annual revenue to help it shrug off weakness in the smartphone market. Cypress Semiconductor Corporation (NASDAQ:CY) shares decreased -1.60% in last trading session and ended the day at $10.43. CY Gross Margin is 48.80% and its return on assets is 0.10%. Cypress Semiconductor Corporation (NASDAQ:CY) quarterly performance is -3.16%.

TheStreet upgraded shares of Cubist Pharmaceuticals (NASDAQ:CBST) from a hold rating to a buy rating in a report released on Monday. Cubist Pharmaceuticals Inc. (NASDAQ:CBST) ended the last trading day at $75.60. Company weekly volatility is calculated as 2.07% and price to cash ratio as 8.40. Cubist Pharmaceuticals Inc. (NASDAQ:CBST) showed a weekly performance of 2.72%.